Fig. 5From: Bacteria‐derived ferrichrome inhibits tumor progression in sporadic colorectal neoplasms and colitis‐associated cancerThe in vivo acute toxicity level of intravenously administered ferrichrome. The serum was collected from the inferior vena cava of 300 mg/kg ferrichrome-treated mice, and biochemical tests were performed. There were no significant changes in the test values of AST, ALT, creatinine or iron. *p < 0.05 by Student’s t-test. The error bars show the standard deviation (S.D.)Back to article page